Oei AL - Search Results

1

Surveillance of women at high risk for hereditary ovarian cancer is inefficient.

Oei AL, Massuger LF, Bulten J, Ligtenberg MJ, Hoogerbrugge N, de Hullu JA. Oei AL, et al. Br J Cancer. 2006 Mar 27;94(6):814-9. doi: 10.1038/sj.bjc.6603015. Br J Cancer. 2006. PMID: 16495917 Free PMC article.

2

Decreased intraperitoneal disease recurrence in epithelial ovarian cancer patients receiving intraperitoneal consolidation treatment with yttrium-90-labeled murine HMFG1 without improvement in overall survival.

Oei AL, Verheijen RH, Seiden MV, Benigno BB, Lopes A, Soper JT, Epenetos AA, Massuger LF. Oei AL, et al. Int J Cancer. 2007 Jun 15;120(12):2710-4. doi: 10.1002/ijc.22663. Int J Cancer. 2007. PMID: 17354223 Clinical Trial.

3

Extraperitoneal leakage as a possible explanation for failure of one-time intraperitoneal treatment in ovarian cancer.

Oei AL, Massuger LF, Oyen WJ. Oei AL, et al. Cancer Biother Radiopharm. 2007 Aug;22(4):508-14. doi: 10.1089/cbr.2007.358A. Cancer Biother Radiopharm. 2007. PMID: 17803445 Free article. Clinical Trial.

4

Development of ELISAs for quantification of HMFG1-specific human anti-mouse IgG and IgM antibodies.

Oei AL, Boerman OC, Geurts-Moespot A, van Eerd JE, van Tienoven D, Courtenay-Luck N, Thomas CM, Massuger LF, Sweep FC. Oei AL, et al. Int J Biol Markers. 2007 Jul-Sep;22(3):167-71. doi: 10.1177/172460080702200301. Int J Biol Markers. 2007. PMID: 17922458 Free article. Clinical Trial.

5

Transient human anti-mouse antibodies (HAMA) interference in CA 125 measurements during monitoring of ovarian cancer patients treated with murine monoclonal antibody.

Oei AL, Sweep FC, Massuger LF, Olthaar AJ, Thomas CM. Oei AL, et al. Gynecol Oncol. 2008 May;109(2):199-202. doi: 10.1016/j.ygyno.2008.01.025. Epub 2008 Mar 4. Gynecol Oncol. 2008. PMID: 18304620 Clinical Trial.

6

The use of monoclonal antibodies for the treatment of epithelial ovarian cancer (review).

Oei AL, Sweep FC, Thomas CM, Boerman OC, Massuger LF. Oei AL, et al. Int J Oncol. 2008 Jun;32(6):1145-57. doi: 10.3892/ijo_32_6_1145. Int J Oncol. 2008. PMID: 18497976 Free article. Review.

7

Induction of IgG antibodies to MUC1 and survival in patients with epithelial ovarian cancer.

Oei AL, Moreno M, Verheijen RH, Sweep FC, Thomas CM, Massuger LF, von Mensdorff-Pouilly S. Oei AL, et al. Int J Cancer. 2008 Oct 15;123(8):1848-53. doi: 10.1002/ijc.23725. Int J Cancer. 2008. PMID: 18661524 Clinical Trial.

8

Human anti-mouse IgM and IgG responses in ovarian cancer patients after radioimmunotherapy with 90Y-muHMFG1.

Oei AL, Sweep FC, Geurts-Moespot A, van Tienoven D, Von Mensdorff-Pouilly S, Thomas CM, Massuger LF. Oei AL, et al. Anticancer Res. 2008 Sep-Oct;28(5A):2721-5. Anticancer Res. 2008. PMID: 19035301 Free article.

9

Improvement of endometrial biopsy over transvaginal ultrasound alone for endometrial surveillance in women with Lynch syndrome.

Gerritzen LH, Hoogerbrugge N, Oei AL, Nagengast FM, van Ham MA, Massuger LF, de Hullu JA. Gerritzen LH, et al. Among authors: oei al. Fam Cancer. 2009;8(4):391-7. doi: 10.1007/s10689-009-9252-x. Epub 2009 Jun 6. Fam Cancer. 2009. PMID: 19504173 Free PMC article.

10

Secondary ovarian malignancies: frequency, origin, and characteristics.

de Waal YR, Thomas CM, Oei AL, Sweep FC, Massuger LF. de Waal YR, et al. Among authors: oei al. Int J Gynecol Cancer. 2009 Oct;19(7):1160-5. doi: 10.1111/IGC.0b013e3181b33cce. Int J Gynecol Cancer. 2009. PMID: 19823050 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

75 results

Search Page

Filters